plasmatic level in patients with allergic rhinitis compared with the values obtained in healthy volunteers. Levocetirizine reduces plasmatic level of IL-6 (1.19 versus 1.006, P ¼ 0.0097) and , P ¼ 0.0003) after 4 weeks treatment, while Desloratadine has influence only IL-6 level (1.68 versus 1.36, P ¼ 0.0038). The intergroup analysis revealed no significant difference between these 2 drugs regarding IL-6 (P ¼ 0.36) and 3 Sanofi, Paris, France. Background: Allergic Rhinitis (AR) is an underappreciated disease considered to be trivial. The small group of patients taking medications for AR are usually seen by specialists. AR is under-diagnosed and under-treated with frequent non-adherence to treatment. There are a gap and unmet needs regarding the management of AR at global level. ISMAR was designed as the first-ever global, quantitative survey to ask to patients and physicians the same questions to identify differences in attitudes and opinions about the treatment of AR at global level with the goal of identifying barriers to optimal management and revealing limitations of currently available treatments. Methods: An international, multicenter, non-interventional, cross-sectional study was conducted in adults or children ($ 6 years). Physicians were selected at random from a master list provided by country and combining private and public practices. ISMAR was designed according to the most accepted epidemiological recommendations based on the successful experience of the WAO-GAPP survey on asthma. A questionnaire addressing patient profiles, diagnostic assessment, therapeutic decisions, and real-life management was answered. The questionnaire also asked about national/local features, medications availability/cost, laboratory test facilities, traditions, geographical constraints, among others. The participating physicians recruited consecutive patients with AR. Study data collection was performed during a single visit with 3 types of documents: Investigator's questionnaire, Case Record Form, Patient's questionnaire. Results: Two-hundred and thirty four physicians were surveyed with a mean age of 49 years (28-69), 180 of them were males (76.9%). The type of medical practice was public sector 16.7%, private practice 41.9% and mixed 41.4%. Regarding medical specialty is a follows: GPs/family practitioners/ internists (22.2%), allergologists/pulmonologists (35.9%), pediatricians (11.1%) and ENT specialist (30.3%). Physicians recruited 2776 patients with AR (Egypt, n ¼ 500; Mexico, n ¼ 418; Brazil, n ¼ 351; Colombia, n ¼ 223; Guatemala, n ¼ 216; Iran, n ¼ 207; Venezuela, n ¼ 201; Argentina, n ¼ 200; Israel, n ¼ 176; Kuwait, n ¼ 150; UAE, n ¼ 134). Conclusions: ISMAR has made possible the participation of physicians from eleven countries in different regions of the world that see AR patients. The doctors surveyed and the patients they recruited will give us the opportunity to gain insight about different aspects of the management of AR at global level. Otorhhinolaryngology, Saitama Medical University, Saitama, Japan. Background: Upper respiratory illness can adversely impact the lower airway. This study aimed to evaluate the relationship between clinical background and improvement in the lower airway after surgery for treatment of chronic rhinosinusitis. Methods: A total of 22 patients with chronic rhinosinusitis surgically treated between January 2010 and February 2011 were included in the study. The presence or absence of asthma and peripheral blood eosinophils count were examined for all patients in addition to preoperative radioallergosorbent tests. Spirometry was conducted and fractional exhaled nitric oxide (NO) was measured at the preoperative, 1-month postoperative, and 3-month postoperative visits. Results: The average level of NO in the exhaled air at the preoperative, 1-month postoperative, and 3-month postoperative visits was 51.5 ppb, 42.5 ppb, and 38.0 ppb, respectively. Although the average results of spirometry didn't show any improvement, forced expiratory volume in 1 second percentage improved in 2 of 4 cases with obstructive ventilatory disturbance. There were 10 improved cases, which were defined as those showing more than 1.2-fold difference in the ratio of preoperative NO level to the 3-month postoperative one. The remaining 12 cases, including 4 of 6 cases with asthma, 5 of 7cases with eosinophilia, and 4 of 4 cases with animal dander allergy were unimproved cases. Conclusions: Chronic rhinosinusitis can cause latent lower respiratory disease. Endoscopic sinus surgery can improve the status of the lower airway. However, the effectiveness of surgery is significantly less in cases of animal dander allergy. The alkaloid has shown pharmacological activities and multiple biological functions such as antibiotic activity, anti-tumor, antiinflammation and anti-fibrotic properties. The purposes of this study were to examine whether berberine has any effect on phenotype change and extracellular matrix production in nasal polyp-derived fibroblasts (NPDFs) and to investigate underlying molecular mechanism. Methods: NPDFs were pre-treated with berberin for 2 hours prior to induction by transforming growth factor (TGF)-b1. The expression of a-smooth muscle actin (SMA) and collagen type I mRNA was determined by a reverse transcription-polymerase chain reaction, and the expression of a-SMA protein and collagen type I was determined by Westernblotting and/ or immunofluoescent staining. Total soluble collagen production was analyzed by the SirCol collagen dye-binding assay. Expression of pSmad 2/3, pp38, pERK 1/2 and pJNK was evaluated by Western blot analysis. Results: In TGF-b1-induced NPDFs, berberine significantly inhibited the expressions of a-SMA and collagen type I mRNA and reduced a-SMA and collagen protein levels. Berberine had no effect on the level of pSmad2/3, pERK1/2 and pJNK expression in TGF-b1-induced NPDFs. However, berberine suppressed the expression of phosphorylated p38 in TGF-b1-induced NPDFs. SB 203580 (a specific inhibitor of p38 kinase) markedly suppresse the increased expression of collagen type I and a-smooth muscle actin (a-SMA) protein in TGF-b1-induced NPDFs. Conclusions: Berberine exerts suppressive effects on phenotype change and extracellular matrix production in NPDFs, through interfering of p38 
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